The U.S. Food and Drug Administration (FDA) has granted PharmaTher Holdings Ltd. (OTCQB: PHRRF) an Orphan Drug designation for ketamine in the prevention of injury from organ transplantation.
https://pcaobus.org/news-events/news-releases/news-release-detail/pcaob-secures-co[…]-to-inspect-investigate-chinese-firms-for-first-time-in-history
Washington, DC, Dec. 15, 2022
Public Company
On December 8, 2022, the United States Bankruptcy Court for the Western District of Pennsylvania (the “Bankruptcy Court”) issued an order that (A) approves the Amended Buyout Agreement, and